Pall Corp. has entered a long-term joint marketing agreement with SOTAX Group that will include Pall Acrodisc PSF syringe filters in all SOTAX dissolution systems for solid dosage forms. The exclusive agreement is the initial step that allows the companies to begin delivering "complete certification solutions that save time and testing costs for quality control laboratories," according to a Pall statement.

The Acrodisc PSF syringe filters are used by research and analytical laboratories to help expedite automated sample processing. First introduced in 1973, the filters provide improved retention efficiency to help extend HPLC column life by as much as 46 times, according to Pall.

SOTAX is a Swiss-based provider of high-quality dissolution testing systems, composite assay and content uniformity workstations along with physical tablet testing instruments for the pharmaceutical industry. At the start of this agreement, all new SOTAX AT 70smart Dissolution systems and SOTAX CTS Content Uniformity test systems will include the Pall Acrodisc PSF syringe filters. Filter refills will be available directly from Pall Life Sciences through its regular sales and distribution channel.

“By exclusively recommending Pall Acrodisc PSF technology as part of our testing systems, we can ensure we are providing the pharmaceutical industry with a significantly improved automated dissolution process for multiple unattended tests. This includes applications for media preparation and delivery, automated dosage introduction, automated sampling, filtering and sample analysis,” said Gilles Devidts, head of product management, SOTAX.